Gastrinoma With Relatively Low Gastrin Levels: A Case Report

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2023 Aug 14

PMID 37575785

Authors

Amelia Winczura

Bob Saggi

David Savage-Lobeck

Affiliations

Soon will be listed here.

Abstract

Gastrinomas can often be cured with surgical removal if detected early enough. We present a case report where a patient was diagnosed with gastrinoma with relatively low serum gastrin levels after subsequent duodenojejunostomy, gastrojejunostomy, total gastrectomy, and cholecystectomy. With this case report, we hope to promote a higher level of awareness of pancreatic neuroendocrine (NE) tumors and educate clinicians on the full effects of proton pump inhibitor (PPI) use on patient workup, diagnostics, and care.

References

Jensen R, Niederle B, Mitry E, Ramage J, Steinmuller T, Lewington V . Gastrinoma (duodenal and pancreatic). Neuroendocrinology. 2007; 84(3):173-82. DOI: 10.1159/000098009. View

Miraglia C, Moccia F, Russo M, Scida S, Franceschi M, Crafa P . Non-invasive method for the assessment of gastric acid secretion. Acta Biomed. 2018; 89(8-S):53-57. PMC: 6502207. DOI: 10.23750/abm.v89i8-S.7986. View

Stabile B, MORROW D, PASSARO Jr E . The gastrinoma triangle: operative implications. Am J Surg. 1984; 147(1):25-31. DOI: 10.1016/0002-9610(84)90029-1. View

Gibril F, Reynolds J, Doppman J, Chen C, Venzon D, Termanini B . Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med. 1996; 125(1):26-34. DOI: 10.7326/0003-4819-125-1-199607010-00005. View

Weber H, Venzon D, Lin J, Fishbein V, Orbuch M, Strader D . Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology. 1995; 108(6):1637-49. DOI: 10.1016/0016-5085(95)90124-8. View

Roy P, Venzon D, Shojamanesh H, Peghini P, Doppman J, Gibril F . Zollinger-Ellison syndrome. Clinical presentation in 261 patients. Medicine (Baltimore). 2001; 79(6):379-411. DOI: 10.1097/00005792-200011000-00004. View

Metz D, Sostek M, Ruszniewski P, Forsmark C, Monyak J, Pisegna J . Effects of esomeprazole on acid output in patients with Zollinger-Ellison syndrome or idiopathic gastric acid hypersecretion. Am J Gastroenterol. 2007; 102(12):2648-54. DOI: 10.1111/j.1572-0241.2007.01509.x. View

Berna M, Hoffmann K, Serrano J, Gibril F, Jensen R . Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature. Medicine (Baltimore). 2006; 85(6):295-330. PMC: 9806863. DOI: 10.1097/01.md.0000236956.74128.76. View

Rehfeld J, Gingras M, Bardram L, Hilsted L, Goetze J, Poitras P . The Zollinger-Ellison syndrome and mismeasurement of gastrin. Gastroenterology. 2011; 140(5):1444-53. DOI: 10.1053/j.gastro.2011.01.051. View

10.

Wong H, Yau T, Chan P, Ng I, Chan G, Hui P . PPI-delayed diagnosis of gastrinoma: oncologic victim of pharmacologic success. Pathol Oncol Res. 2009; 16(1):87-91. PMC: 2953631. DOI: 10.1007/s12253-009-9192-7. View

11.

Thakker R, Newey P, Walls G, Bilezikian J, Dralle H, Ebeling P . Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J Clin Endocrinol Metab. 2012; 97(9):2990-3011. DOI: 10.1210/jc.2012-1230. View

12.

Dhillo W, Jayasena C, Lewis C, Martin N, Tang K, Meeran K . Plasma gastrin measurement cannot be used to diagnose a gastrinoma in patients on either proton pump inhibitors or histamine type-2 receptor antagonists. Ann Clin Biochem. 2006; 43(Pt 2):153-5. DOI: 10.1258/000456306776021607. View

13.

Gibril F, Jensen R . Diagnostic uses of radiolabelled somatostatin receptor analogues in gastroenteropancreatic endocrine tumours. Dig Liver Dis. 2004; 36 Suppl 1:S106-20. DOI: 10.1016/j.dld.2003.11.024. View

14.

Kulke M, Anthony L, Bushnell D, de Herder W, Goldsmith S, Klimstra D . NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. 2010; 39(6):735-52. PMC: 3100728. DOI: 10.1097/MPA.0b013e3181ebb168. View

15.

Metz D, Comer G, Soffer E, Forsmark C, Cryer B, Chey W . Three-year oral pantoprazole administration is effective for patients with Zollinger-Ellison syndrome and other hypersecretory conditions. Aliment Pharmacol Ther. 2006; 23(3):437-44. PMC: 6736592. DOI: 10.1111/j.1365-2036.2006.02762.x. View

16.

Zimmer T, Stolzel U, Bader M, Koppenhagen K, Hamm B, Buhr H . Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. Gut. 1996; 39(4):562-8. PMC: 1383270. DOI: 10.1136/gut.39.4.562. View

17.

Norton J, Jensen R . Current surgical management of Zollinger-Ellison syndrome (ZES) in patients without multiple endocrine neoplasia-type 1 (MEN1). Surg Oncol. 2003; 12(2):145-51. DOI: 10.1016/s0960-7404(03)00035-5. View

18.

Alexander H, Fraker D, Norton J, Bartlett D, Tio L, Benjamin S . Prospective study of somatostatin receptor scintigraphy and its effect on operative outcome in patients with Zollinger-Ellison syndrome. Ann Surg. 1998; 228(2):228-38. PMC: 1191465. DOI: 10.1097/00000658-199808000-00013. View

19.

Metz D, Cadiot G, Poitras P, Ito T, Jensen R . Diagnosis of Zollinger-Ellison syndrome in the era of PPIs, faulty gastrin assays, sensitive imaging and limited access to acid secretory testing. Int J Endocr Oncol. 2018; 4(4):167-185. PMC: 5757869. DOI: 10.2217/ije-2017-0018. View

20.

Oberg K . Pancreatic endocrine tumors. Semin Oncol. 2010; 37(6):594-618. DOI: 10.1053/j.seminoncol.2010.10.014. View